Inc. reaches a milestone in prostate cancer diagnostics with its clinically validated SUREcore® biopsy needle and coreCARE® ...

Most clinicians do not use ultrasound to detect prostate cancer or to target suspicious lesions for biopsy owing to the inaccuracies of identifying the tumor with standard ultrasound techniques.

The prostate is a gland, often described as walnut-sized, which sits under the bladder in those assigned male at birth. The ...

Experts and stakeholders have urged governments and policymakers in Africa to make better investments in healthcare for ...

Biopsy results confirmed a Gleason score of 3+4 (Grade Group 2) prostate cancer. The patient underwent focal ... 9 In terms of MRI-guided high-intensity focused ultrasound (HIFU), one of the landmark ...

An AI test boosts cure chances for prostate cancer by predicting who benefits from abiraterone, reducing side effects and ...

Metastatic prostate cancer can progress in different ways. In some men the disease advances rapidly, while other men have ...

Alexander Kenigsberg, MD, discusses a new option for treating prostate cancer: robotic high-intensity focused ultrasound.

level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of prospective data on the predictive value of PSA levels below this threshold. To analyse the ...

The global biopsy guidance system market is on a trajectory of remarkable growth, with projections estimating a Compound Annual Growth Rate (CAGR) of 5.8% from 2022 to 2032, according to a new report ...

The interventional oncology market is projected to grow at a CAGR of 11% over the forecast period. Major factors driving ...